Europe Smart Pills Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Sep 2020
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Smart Pills Market, By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Stomach, Large Intestine), Disease Indication (Esophageal Diseases, Small Bowl Diseases, Colon Diseases, Others), End Users (Hospitals, Diagnostic Center, Research Institute), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland and Rest of Europe) Industry Trends and Forecast to 2027

Europe Smart Pills Market

Market Analysis and Insights: Europe Smart Pills Market

Europe smart pills market is expected to gain market grow that a potential rate of 15.20% in the forecast period of 2020 to 2027.

Smart pills can be defined as capsule sized medical device which includes sensors, cameras, patches and trackers that aid efficient diagnostic, targeted drug delivery, and patient monitoring. It helps to analyse health condition of patient once patient swallow the pill which helps in taking effective decision for prescribing medications. In addition smart pills have got revolutionized in the field of gastrointestinal diagnosis.

Rising geriatric population and increasing prevalence of chronic diseases such as diabetes, cancer, obesity, gastroesophageal reflux diseases, gastric ulcers and others are major factor driving market growth whereas rising demand for minimal invasive treatment with early detection of medical problems, technological advancement and innovation of new products such as bioelectronics, micro-cameras, miniatururizartion and others will boost market growth. In addition increasing R&D projects for development of effective smart pills will create lucrative opportunities for market in coming years. However strict regulatory policies and high cost of devices are restraining factors for market whereas side effects of treatment are challenging factors for market.

This Europe smart pills market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Smart Pills Market Scope and Market Size

Europe smart pills market is segmented on the basis of application, target area, disease indication, and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • Based on application, Europe smart pills market is segmented into capsule endoscopy, drug delivery, and patient monitoring.
  • Based on target area, Europe smart pills market is segmented into esophagus, small intestine, large intestine, and stomach.
  • Based on disease indication, Europe smart pills market is segmented into esophageal diseases, small bowel diseases, colon diseases, and others.
  • Europe smart pills market is also segmented on the basis of end user is segmented into hospitals, diagnostic centers, and research institute.

Europe Smart Pills Market Country Level Analysis

Europe smart pills market is analysed and market size information is provided by country, application, target area, disease indication and end users as referenced above.

The countries covered in the Europe smart pills market report are Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe.

Germany, France and U.K. are anticipated to register significant market growth rate during forecast period owing to high pace in technological development and increasing government initiative to improve healthcare infrastructure whereas rising of geriatric population and increasing prevalence of chronic diseases due to changing lifestyle will boost region market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Europe smart pills market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Europe Smart Pills Market Share Analysis

Europe smart pills market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to bone anchored hearing systems market.

The major players covered in the Europe smart pills market report are Boston Scientific Corporation, GENERAL ELECTRIC COMPANY, Medtronic, Microchip Technology Inc., Novartis AG, Olympus Medical Technology, Koninklike Philips N.V., Pixie Scientific, LLC, Proteus Digital Health, FUJIFILM Holding Corporation, INTROMEDIC, MEDISAFE, Check-Cap, PENTAX Medical, JINSHAN Science & Technology, CapsoVision, HQ Inc., Medimetriks Pharmaceuticals Inc., BDD Pharma, Lucid group Communication Ltd, Otsuka Holdings Co. Ltd. Cerner Corporation, and Vitality among other domestic and global players. Bone anchored hearing systems market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Europe Smart Pills Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES EUROPE SMART PILLS MARKET

TABLE 1 DIFFERENT CURRENT PROCEDURAL TERMINOLOGY (CPT) CODES FOR CAPSULE ENDOSCOPY PROCEDURES

TABLE 2 PRICES FOR THE CAPSULE ENDOSCOPY

TABLE 3 EUROPE SMART PILLS MARKET, BY APPLICATION, 2016-2025, (USD MILLION)

TABLE 4 EUROPE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 5 EUROPE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 6 EUROPE DRUG DELIVERY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 7 EUROPE PATIENT MONITORING OF CANCER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 8 EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025, (USD MILLION)

TABLE 9 EUROPE OCCULT GI BLEEDING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 10 EUROPE CROHN’S DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 11 EUROPE SMALL BOWEL TUMORS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 12 EUROPE CELIAC DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 13 EUROPE INHERITED POLYPOSIS SYNDROMES IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 14 EUROPE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 15 EUROPE MENTAL DISORDERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 16 EUROPE SMART PILLS MARKET, BY TYPE, 2016-2025, (USD MILLION)

TABLE 17 EUROPE MULTIPARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 18 EUROPE SINGLE PARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 19 EUROPE SMART PILLS MARKET, BY END USER, 2016-2025, (USD MILLION)

TABLE 20 EUROPE HOSPITAL IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 21 EUROPE DIAGNOSTIC CENTERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 22 EUROPE OTHERS END USER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 23 EUROPE SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)

TABLE 24 EUROPE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 25 EUROPE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 26 EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 27 EUROPE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 28 EUROPE SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 29 EUROPE SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 30 GERMANY SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 31 GERMANY CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 32 GERMANY SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 33 GERMANY MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 34 GERMANY SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 35 GERMANY SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 36 FRANCE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 37 FRANCE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 38 FRANCE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 39 FRANCE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 40 FRANCE SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 41 FRANCE SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 42 U.K. SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 43 U.K. CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 44 U.K. SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 45 U.K. MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 46 U.K. SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 47 U.K. SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 48 ITALY SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 49 ITALY CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 50 ITALY SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 51 ITALY MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 52 ITALY SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 53 ITALY SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 54 SPAIN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 55 SPAIN CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 56 SPAIN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 57 SPAIN MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 58 SPAIN SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 59 SPAIN SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 60 SWITZERLAND SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 61 SWITZERLAND CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 62 SWITZERLAND SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 63 SWITZERLAND MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 64 SWITZERLAND SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 65 SWITZERLAND SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 66 NETHERLANDS SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 67 NETHERLANDS CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 68 NETHERLANDS SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 69 NETHERLANDS MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 70 NETHERLANDS SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 71 NETHERLANDS SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 72 RUSSIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 73 RUSSIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 74 RUSSIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 75 RUSSIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 76 RUSSIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 77 RUSSIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 78 BELGIUM SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 79 BELGIUM CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 80 BELGIUM SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 81 BELGIUM MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 82 BELGIUM SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 83 BELGIUM SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 84 TURKEY SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 85 TURKEY CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 86 TURKEY SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 87 TURKEY MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 88 TURKEY SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 89 TURKEY SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 90 REST OF EUROPE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19